Lucibru 140 mg


Lucibru 140 mg

Introduction to Lucibru 140 mg

Lucibru 140 , meticulously developed by Lucius Pharmaceutical Ltd and supplied by Orio Pharma, represents a significant advancement in the treatment of breast cancer. The active ingredient in Lucibru, a potent anticancer agent, offers a targeted approach, providing hope and improved outcomes for individuals battling breast cancer.

Description: Lucibru 140 mg

Lucibru 140 contains a powerful therapeutic agent designed to combat breast cancer at a cellular level. This medication is formulated to interfere with the growth and spread of cancer cells, offering a targeted and effective treatment option.

Mechanism of Action

Lucibru 140 works by targeting specific pathways involved in the growth and proliferation of cancer cells. By inhibiting these pathways, Lucibru effectively suppresses tumor growth and aids in preventing the spread of cancer within the body.

Clinical Use

Lucibru 140 is primarily indicated for:

  • Breast Cancer Treatment: Prescribed for the treatment of advanced or metastatic breast cancer, providing a potent option to manage the disease.

Dosage and Administration

Healthcare professionals determine the appropriate dosage of Lucibru 140 based on the specific condition and the individual patient’s response. Administered according to a precise schedule, adherence to the prescribed regimen is crucial for achieving optimal results.

Benefits of Lucibru 140 mg

  • Targeted Therapy: Lucibru’s precise mechanism of action targets cancer cells, minimizing damage to healthy cells.
  • Tumor Growth Suppression: Effectively inhibits tumor growth, leading to disease stabilization and potentially improved survival rates.
  • Advanced Treatment: Offers a modern, advanced treatment option for individuals with breast cancer, improving their quality of life and treatment outcomes.

Manufacturer: Lucius Pharmaceutical Ltd

Lucius Pharmaceutical Ltd, the esteemed manufacturer of Lucibru 140 , is dedicated to producing high-quality anticancer medications. Their commitment to innovation and stringent quality control ensures that Lucibru meets the highest standards of efficacy and safety.

Supplier: Orio Pharma

Orio Pharma, the trusted supplier of Lucibru 140 , ensures that this crucial medication is accessible to healthcare providers and patients worldwide. Their dedication to excellence in distribution guarantees timely and reliable access to Lucibru.

Storage Conditions

Store Lucibru 140 tablets at room temperature, between 20°C to 25°C (68°F to 77°F). Protect from moisture and light. Keep the tablets in their original container and keep out of reach of children.


In conclusion, Lucibru 140 is a groundbreaking medication for the treatment of advanced breast cancer. Manufactured by Lucius Pharmaceutical Ltd and supplied by Orio Pharma, this treatment offers a targeted and effective approach to combatting breast cancer.

The innovative action of Lucibru underscores its role as a potent therapeutic option. The collaboration between Lucius Pharmaceutical Ltd and Orio Pharma ensures the highest standards of manufacturing and distribution, making Lucibru 140 a reliable and accessible option for patients seeking improved outcomes in their fight against breast cancer.